금융 뉴스 허브

3 Reasons to Avoid PFS and 1 Stock to Buy Instead

Provident Financial Services trades at $22.05 and has moved in lockstep with the market. Its shares have returned 13.3% over the last six months while the S&P 500 has gained 10%.

Is Now the Time to Add an International ETF to Your Core Holdings?

The best investors are always thinking about ways they can upgrade their portfolios.

Owens Corning (OC): Buy, Sell, or Hold Post Q1 Earnings?

Owens Corning trades at $117.16 and has moved in lockstep with the market. Its shares have returned 7.2% over the last six months while the S&P 500 has gained 10%.

Does Planet Fitness (PLNT) Offer a Strong Foundation For Long-Term Value Creation?

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. In the ...

MCY Outperforms Industry in a Year: Time to Add It for Better Returns?

Mercury General gains from steady premium growth, higher investment income and strong liquidity, which support long-term expansion.

Alger Weatherbie Specialized Growth Fund Hold StepStone Group (STEP) Despite Challenges

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. In the ...

AAR Corp (AIR) Rallied on Strong Earnings Report

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. In the ...

3 Reasons ALLY is Risky and 1 Stock to Buy Instead

Ally Financial currently trades at $42.33 per share and has shown little upside over the past six months, posting a middling return of 3.9%. The stock also fell short of the S&P 500’s 10% gain during ...

Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?

VCYT jumps 65.8% in a year as Afirma and Decipher volumes surge, guidance lifts, and TrueMRD nears launch with $439M cash and no debt.

3 Reasons NVAX is Risky and 1 Stock to Buy Instead

Novavax has had an impressive run over the past six months as its shares have beaten the S&P 500 by 27.6%. The stock now trades at $9.21, marking a 37.6% gain. This was partly due to its solid quarter ...

MCY Outperforms Industry in a Year: Time to Add It for Better Returns?

Mercury General gains from steady premium growth, higher investment income and strong liquidity, which support long-term expansion.

SA Asks: What's next for OpenAI after its court win against Elon Musk?